Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Cell Mol Immunol ; 18(6): 1602-1604, 2021 06.
Article in English | MEDLINE | ID: covidwho-1223085
2.
Nat Commun ; 12(1): 2133, 2021 04 09.
Article in English | MEDLINE | ID: covidwho-1174672

ABSTRACT

Our understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still developing. We perform an observational study to investigate seroprevalence and immune responses in subjects professionally exposed to SARS-CoV-2 and their family members (155 individuals; ages 5-79 years). Seropositivity for SARS-CoV-2 Spike glycoprotein aligns with PCR results that confirm the previous infection. Anti-Spike IgG/IgM titers remain high 60 days post-infection and do not strongly associate with symptoms, except for fever. We analyze PBMCs from a subset of seropositive and seronegative adults. TLR7 agonist-activation reveals an increased population of IL-6+TNF-IL-1ß+ monocytes, while SARS-CoV-2 peptide stimulation elicits IL-33, IL-6, IFNa2, and IL-23 expression in seropositive individuals. IL-33 correlates with CD4+ T cell activation in PBMCs from convalescent subjects and is likely due to T cell-mediated effects on IL-33-producing cells. IL-33 is associated with pulmonary infection and chronic diseases like asthma and COPD, but its role in COVID-19 is unknown. Analysis of published scRNAseq data of bronchoalveolar lavage fluid (BALF) from patients with mild to severe COVID-19 reveals a population of IL-33-producing cells that increases with the disease. Together these findings show that IL-33 production is linked to SARS-CoV-2 infection and warrant further investigation of IL-33 in COVID-19 pathogenesis and immunity.


Subject(s)
Antibodies, Viral/immunology , COVID-19/immunology , Immunoglobulin G/immunology , Interleukin-33/immunology , SARS-CoV-2/immunology , Spike Glycoprotein, Coronavirus/immunology , Adolescent , Adult , Aged , COVID-19/virology , Child , Child, Preschool , Female , Humans , Interleukin-33/metabolism , Male , Middle Aged , SARS-CoV-2/genetics , SARS-CoV-2/physiology , Seroepidemiologic Studies , Spike Glycoprotein, Coronavirus/genetics , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Young Adult
3.
Sci Rep ; 10(1): 21415, 2020 12 08.
Article in English | MEDLINE | ID: covidwho-970024

ABSTRACT

The COVID-19 pandemic resulting from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which emerged in December 2019 in Wuhan in China has placed immense burden on national economies and global health. At present neither vaccination nor therapies are available. Here, we performed a meta-analysis of RNA-sequencing data from three studies employing human lung epithelial cells. Of these one focused on lung epithelial cells infected with SARS-CoV-2. We aimed at identifying genes co-expressed with angiotensin I converting enzyme 2 (ACE2) the human cell entry receptor of SARS-CoV-2, and unveiled several genes correlated or inversely correlated with high significance, among the most significant of these was the transmembrane serine protease 4 (TMPRSS4). Serine proteases are known to be involved in the infection process by priming the virus spike protein. Pathway analysis revealed virus infection amongst the most significantly correlated pathways. Gene Ontologies revealed regulation of viral life cycle, immune responses, pro-inflammatory responses- several interleukins such as IL6, IL1, IL20 and IL33, IFI16 regulating the interferon response to a virus, chemo-attraction of macrophages, and cellular stress resulting from activated Reactive Oxygen Species. We believe that this dataset will aid in a better understanding of the molecular mechanism(s) underlying COVID-19.


Subject(s)
Angiotensin-Converting Enzyme 2/metabolism , Epithelial Cells/metabolism , Membrane Proteins/metabolism , Respiratory Mucosa/metabolism , SARS-CoV-2/metabolism , Serine Endopeptidases/metabolism , Angiotensin-Converting Enzyme 2/genetics , COVID-19/pathology , Computational Biology , Humans , Interleukin-1beta/immunology , Interleukin-33/immunology , Interleukin-6/immunology , Interleukins/immunology , Lung/cytology , Membrane Proteins/genetics , Nuclear Proteins/immunology , Phosphoproteins/immunology , Reactive Oxygen Species/metabolism , Receptors, Virus/genetics , Receptors, Virus/metabolism , Respiratory Mucosa/cytology , Serine Endopeptidases/genetics , Transcriptome/genetics
SELECTION OF CITATIONS
SEARCH DETAIL